$29.37
0.802.80%
al cierre: -
$29.37
N/A
After hour: 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Braze Inc tiene un precio objetivo de consenso de $46.59 basado en las calificaciones de 27 analistas. El máximo es $68, emitido por JMP Securities el septiembre 5, 2025. El mínimo es $30, emitido por Macquarie el octubre 31, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por Needham, Wells Fargo y Piper Sandler el octubre 22, 2025, octubre 1, 2025 y octubre 1, 2025, respectivamente. Con un precio objetivo promedio de $46.67 entre Needham, Wells Fargo y Piper Sandler, hay una 58.89% upside implícita para Braze Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Needham
Wells Fargo
Piper Sandler
Citigroup
Canaccord Genuity
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Braze
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/22/2025 | 70.24% | Needham | $50 → $50 | Reiterates | Buy → Buy | |||
10/01/2025 | 36.19% | Wells Fargo | → $40 | Initiates | → Overweight | |||
10/01/2025 | 70.24% | Piper Sandler | $50 → $50 | Reiterates | Overweight → Overweight | |||
09/05/2025 | 77.05% | Citigroup | $50 → $52 | Maintains | Buy | |||
09/05/2025 | 46.41% | Canaccord Genuity | $43 → $43 | Maintains | Buy | |||
09/05/2025 | 53.22% | Mizuho | $40 → $45 | Maintains | Outperform | |||
09/05/2025 | 46.41% | UBS | $48 → $43 | Maintains | Buy | |||
09/05/2025 | 29.38% | Cantor Fitzgerald | $35 → $38 | Maintains | Overweight | |||
09/05/2025 | 131.53% | JMP Securities | $68 → $68 | Reiterates | Market Outperform → Market Outperform | |||
09/05/2025 | 32.79% | Barclays | $35 → $39 | Maintains | Overweight | |||
09/05/2025 | 36.19% | DA Davidson | $40 → $40 | Assumes | Buy → Buy | |||
09/05/2025 | 70.24% | Needham | $50 → $50 | Reiterates | Buy → Buy | |||
09/05/2025 | 70.24% | Piper Sandler | $38 → $50 | Maintains | Overweight | |||
08/29/2025 | 19.17% | Cantor Fitzgerald | $45 → $35 | Maintains | Overweight | |||
08/18/2025 | 19.17% | Barclays | $43 → $35 | Maintains | Overweight | |||
07/24/2025 | 36.19% | Mizuho | → $40 | Initiates | → Outperform | |||
06/24/2025 | 29.38% | Oppenheimer | $44 → $38 | Maintains | Outperform | |||
06/06/2025 | 46.41% | Raymond James | $48 → $43 | Maintains | Outperform | |||
06/06/2025 | 49.81% | Oppenheimer | $51 → $44 | Maintains | Outperform | |||
06/06/2025 | 19.17% | Macquarie | $40 → $35 | Maintains | Neutral | |||
06/06/2025 | 53.22% | Loop Capital | $75 → $45 | Maintains | Buy | |||
06/06/2025 | 53.22% | JP Morgan | $47 → $45 | Maintains | Overweight | |||
06/06/2025 | 63.43% | UBS | $51 → $48 | Maintains | Buy | |||
06/06/2025 | 131.53% | JMP Securities | $68 → $68 | Reiterates | Market Outperform → Market Outperform | |||
06/06/2025 | 39.6% | Stephens & Co. | $51 → $41 | Maintains | Overweight | |||
06/06/2025 | 70.24% | Needham | $50 → $50 | Reiterates | Buy → Buy | |||
06/03/2025 | 53.22% | Cantor Fitzgerald | → $45 | Initiates | → Overweight | |||
05/16/2025 | 60.03% | Barclays | $70 → $47 | Maintains | Overweight | |||
04/23/2025 | 29.38% | Piper Sandler | $48 → $38 | Maintains | Overweight | |||
04/22/2025 | 36.19% | Wells Fargo | $55 → $40 | Maintains | Overweight | |||
04/14/2025 | 36.19% | DA Davidson | $50 → $40 | Maintains | Buy | |||
03/31/2025 | 36.19% | Macquarie | $39 → $40 | Maintains | Neutral | |||
03/28/2025 | 63.43% | Raymond James | $45 → $48 | Maintains | Outperform | |||
03/28/2025 | 87.27% | Citigroup | $50 → $55 | Maintains | Buy | |||
03/28/2025 | 70.24% | Canaccord Genuity | $45 → $50 | Maintains | Buy | |||
03/28/2025 | 131.53% | Citizens Capital Markets | $68 → $68 | Reiterates | Market Outperform → Market Outperform | |||
03/28/2025 | 87.27% | Wells Fargo | $50 → $55 | Maintains | Overweight | |||
03/28/2025 | 70.24% | Stifel | $48 → $50 | Maintains | Buy | |||
03/28/2025 | 70.24% | Needham | $50 → $50 | Reiterates | Buy → Buy | |||
03/26/2025 | 70.24% | DA Davidson | $50 → $50 | Maintains | Buy | |||
03/21/2025 | 70.24% | Wells Fargo | $55 → $50 | Maintains | Overweight | |||
03/20/2025 | 53.22% | Raymond James | $48 → $45 | Maintains | Outperform | |||
03/19/2025 | 46.41% | Stephens & Co. | → $43 | Initiates | → Overweight | |||
02/03/2025 | 70.24% | Needham | $50 → $50 | Reiterates | Buy → Buy | |||
01/15/2025 | 70.24% | Needham | $50 → $50 | Reiterates | Buy → Buy | |||
12/11/2024 | 73.65% | Citigroup | $47 → $51 | Maintains | Buy | |||
12/11/2024 | 32.79% | Macquarie | $30 → $39 | Maintains | Neutral | |||
12/10/2024 | 70.24% | DA Davidson | $55 → $50 | Maintains | Buy | |||
12/10/2024 | 63.43% | Stifel | $37 → $48 | Maintains | Buy | |||
12/10/2024 | 73.65% | Oppenheimer | $51 → $51 | Maintains | Outperform | |||
12/10/2024 | 70.24% | Needham | $70 → $50 | Reiterates | Buy → Buy | |||
12/10/2024 | 63.43% | Piper Sandler | $40 → $48 | Maintains | Overweight | |||
11/26/2024 | 87.27% | Wells Fargo | $65 → $55 | Maintains | Overweight | |||
11/12/2024 | 60.03% | Goldman Sachs | $65 → $47 | Maintains | Buy | |||
10/31/2024 | 2.15% | Macquarie | — | → $30 | Initiates | → Neutral | ||
10/25/2024 | 60.03% | JP Morgan | $55 → $47 | Maintains | Overweight | |||
10/22/2024 | 25.98% | Stifel | → $37 | Initiates | → Buy | |||
10/10/2024 | 36.19% | Piper Sandler | $51 → $40 | Maintains | Overweight | |||
09/25/2024 | 73.65% | UBS | $56 → $51 | Maintains | Buy | |||
09/24/2024 | 87.27% | DA Davidson | $65 → $55 | Maintains | Buy | |||
09/24/2024 | 53.22% | TD Cowen | $52 → $45 | Maintains | Buy | |||
09/24/2024 | 131.53% | JMP Securities | $68 → $68 | Reiterates | Market Outperform → Market Outperform | |||
09/24/2024 | 155.36% | Loop Capital | $75 → $75 | Reiterates | Buy → Buy | |||
09/24/2024 | 73.65% | Oppenheimer | $60 → $51 | Maintains | Outperform | |||
09/24/2024 | 138.34% | Needham | $70 → $70 | Reiterates | Buy → Buy | |||
09/06/2024 | 121.31% | DA Davidson | $65 → $65 | Maintains | Buy | |||
09/06/2024 | 131.53% | JMP Securities | $68 → $68 | Reiterates | Market Outperform → Market Outperform | |||
09/06/2024 | 138.34% | Needham | $70 → $70 | Reiterates | Buy → Buy | |||
09/06/2024 | 73.65% | Piper Sandler | $51 → $51 | Maintains | Overweight | |||
08/26/2024 | 138.34% | Barclays | $80 → $70 | Maintains | Overweight | |||
07/12/2024 | 73.65% | Piper Sandler | $55 → $51 | Maintains | Overweight | |||
07/10/2024 | 90.67% | Scotiabank | $48 → $56 | Upgrade | Sector Perform → Sector Outperform | |||
06/17/2024 | 138.34% | Needham | $70 → $70 | Reiterates | Buy → Buy | |||
06/12/2024 | 104.29% | Oppenheimer | $60 → $60 | Maintains | Outperform | |||
06/10/2024 | 138.34% | Needham | $70 → $70 | Reiterates | Buy → Buy | |||
06/07/2024 | 97.48% | Citigroup | $52 → $58 | Maintains | Buy | |||
06/07/2024 | 131.53% | JMP Securities | $68 → $68 | Reiterates | Market Outperform → Market Outperform | |||
06/07/2024 | 87.27% | Raymond James | $65 → $55 | Maintains | Outperform | |||
06/07/2024 | 87.27% | Piper Sandler | $66 → $55 | Maintains | Overweight | |||
06/07/2024 | 80.46% | Canaccord Genuity | $50 → $53 | Maintains | Buy | |||
06/07/2024 | 138.34% | Needham | $70 → $70 | Reiterates | Buy → Buy | |||
06/03/2024 | 63.43% | Scotiabank | $58 → $48 | Maintains | Sector Perform | |||
05/31/2024 | 77.05% | TD Cowen | $65 → $52 | Maintains | Buy | |||
05/31/2024 | 111.1% | BTIG | $68 → $62 | Maintains | Buy | |||
05/29/2024 | 104.29% | Oppenheimer | $75 → $60 | Reiterates | Outperform → Outperform | |||
04/29/2024 | 121.31% | Wells Fargo | $75 → $65 | Maintains | Overweight | |||
04/22/2024 | 70.24% | Canaccord Genuity | $65 → $50 | Maintains | Buy | |||
04/05/2024 | 124.72% | Piper Sandler | $66 → $66 | Maintains | Overweight | |||
03/28/2024 | 138.34% | Needham | $70 → $70 | Reiterates | Buy → Buy | |||
03/28/2024 | 121.31% | Raymond James | $75 → $65 | Maintains | Outperform | |||
03/28/2024 | 121.31% | TD Cowen | $68 → $65 | Maintains | Buy | |||
03/28/2024 | 121.31% | DA Davidson | $65 → $65 | Maintains | Buy | |||
03/28/2024 | 97.48% | Scotiabank | $65 → $58 | Maintains | Sector Perform | |||
03/28/2024 | 97.48% | JP Morgan | $60 → $58 | Maintains | Overweight | |||
03/28/2024 | 155.36% | Oppenheimer | → $75 | Reiterates | Outperform → Outperform | |||
03/28/2024 | 121.31% | Canaccord Genuity | $70 → $65 | Maintains | Buy | |||
03/28/2024 | 124.72% | Piper Sandler | $66 → $66 | Maintains | Overweight | |||
03/25/2024 | 121.31% | DA Davidson | $65 → $65 | Maintains | Buy | |||
03/21/2024 | 111.1% | UBS | → $62 | Upgrade | Neutral → Buy | |||
12/07/2023 | 121.31% | DA Davidson | $53 → $65 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Braze (BRZE)?
El último precio objetivo de Braze (NASDAQ:BRZE) fue comunicado por Needham el octubre 22, 2025. La firma de analistas fijó un precio objetivo para $50.00 que espera BRZE a rise dentro de 12 meses (un posible 70.24% upside). 53 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Braze (BRZE)?
La última calificación de analistas para Braze (NASDAQ:BRZE) fue proporcionada por Needham, y Braze reiterado su buy calificación.
¿Cuándo se produjo la última revisión al alza de Braze (BRZE)?
La última revisión al alza de Braze Inc se produjo en julio 10, 2024, cuando Scotiabank elevó su precio objetivo a $56. Scotiabank anteriormente tenía a sector perform para Braze Inc.
¿Cuándo fue la última revisión a la baja de Braze (BRZE)?
No hay una última revisión a la baja para Braze.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Braze (BRZE)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Braze, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Braze se registró el octubre 22, 2025, por lo que la próxima calificación estará disponible en torno al octubre 22, 2026.
¿Es correcta la calificación de los analistas sobre Braze (BRZE)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Braze (BRZE) fue un reiterado con un precio objetivo de $50.00 a $50.00. El precio actual al que cotiza Braze (BRZE) es de $29.37, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.